Quick Answer
Fortress Biotech, Inc. reported Stockholders Equity of $49.87 million for fiscal year 2025.
Fortress Biotech, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $49.87M | +119.3% |
| 2024 | $22.74M | +0.9% |
| 2023 | $22.54M | -46.0% |
| 2022 | $41.72M | -61.6% |
| 2021 | $108.67M | +8.3% |
| 2020 | $100.34M | +282.8% |
| 2019 | $26.21M | +1315.5% |
| 2018 | $1.85M | -96.5% |
| 2017 | $52.57M | +36.6% |
| 2016 | $38.49M | -32.3% |
| 2015 | $56.85M | -19.4% |
| 2014 | $70.52M | -13.2% |
| 2013 | $81.28M | +268.9% |
| 2012 | $22.03M | +15.2% |
| 2011 | $19.13M | +220.3% |
| 2010 | -$15.90M | +0.0% |
| 2009 | -$15.90M | -318040.0% |
| 2008 | $5.0K | +100.2% |
| 2007 | -$2.75M | -2135.0% |
| 2006 | -$123.0K | — |
| 2006 | $0.00 | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $55.86M | +164.0% | +27.2% |
| June 30, 2025 | $43.92M | +145.7% | +97.4% |
| March 31, 2025 | $22.25M | -3.4% | -2.1% |
| December 31, 2024 | $22.74M | +0.9% | +7.5% |
| September 30, 2024 | $21.16M | +26.9% | +18.4% |
| June 30, 2024 | $17.88M | -3.4% | -22.4% |
| March 31, 2024 | $23.02M | -39.1% | +2.1% |
| December 31, 2023 | $22.54M | -46.0% | +35.2% |
- Fortress Biotech, Inc. showed an increase of +119.3% in Stockholders Equity compared to the prior fiscal year.
- The most recent figure is from Fortress Biotech, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: